What is the most recent earnings date for CSTL stock?
CASTLE BIOSCIENCES INC (CSTL) last reported earnings on 2/26/2026.
NASDAQ:CSTL • US14843C1053
Past quarterly earnings results for CASTLE BIOSCIENCES INC (CSTL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.08 | -0.29 | 72.60% | -124.24% | 87.01M | 80.629M | 7.91% | 0.81% |
| Q3 2025 | -0.02 | -0.53 | 96.25% | -125.00% | 83.043M | 72.633M | 14.33% | -3.19% |
| Q2 2025 | 0.15 | -0.53 | 128.10% | -51.61% | 86.188M | 72.833M | 18.34% | -0.94% |
| Q1 2025 | -0.20 | -0.07 | -175.74% | -122.22% | 87.988M | 81.946M | 7.37% | 20.57% |
| Q4 2024 | 0.33 | 0.05 | 558.79% | 430.00% | 86.311M | 83.549M | 3.31% | 30.54% |
| Q3 2024 | 0.08 | -0.06 | 223.11% | 130.77% | 85.782M | 81.439M | 5.33% | 39.50% |
| Q2 2024 | 0.31 | -0.27 | 213.12% | 144.29% | 87.002M | 70.727M | 23.01% | 73.53% |
| Q1 2024 | -0.09 | -0.34 | 73.41% | 91.82% | 72.974M | 67.523M | 8.07% | 73.59% |
| Q4 2023 | -0.10 | -0.55 | 81.72% | 87.18% | 66.12M | 57.407M | 15.18% | 72.46% |
| Q3 2023 | -0.26 | -0.78 | 66.62% | 66.23% | 61.493M | 49.493M | 24.25% | 66.15% |
| Q2 2023 | -0.70 | -0.93 | 25.00% | -1,066.67% | 50.138M | 45.078M | 11.22% | 43.91% |
| Q1 2023 | -1.10 | -0.91 | -21.00% | -13.40% | 42.037M | 38.119M | 10.28% | 56.56% |
| Q4 2022 | -0.78 | -0.85 | 8.69% | -212.00% | 38.34M | 37.9M | 1.16% | 53.12% |
| Q3 2022 | -0.77 | -0.90 | 14.22% | -63.83% | 37.01M | 35.447M | 4.41% | 57.62% |
| Q2 2022 | -0.06 | -0.78 | 92.27% | 82.35% | 34.84M | 28.943M | 20.37% | 53.08% |
| Q1 2022 | -0.97 | -0.72 | -34.48% | -470.59% | 26.85M | 25.718M | 4.40% | 17.71% |
| Q4 2021 | -0.25 | -0.48 | 47.85% | -47.06% | 25.04M | 24.211M | 3.42% | 44.74% |
| Q3 2021 | -0.47 | -0.41 | -13.77% | -104.35% | 23.48M | 23.426M | 0.23% | 54.27% |
| Q2 2021 | -0.34 | -0.37 | 8.93% | -78.95% | 22.76M | 19.298M | 17.94% | 78.93% |
| Q1 2021 | -0.17 | -0.24 | 29.08% | -666.67% | 22.81M | 17.05M | 33.78% | 30.94% |
| Q4 2020 | -0.17 | -0.12 | -36.61% | - | 17.3M | 16.056M | 7.75% | - |
| Q3 2020 | -0.23 | -0.12 | -96.08% | - | 15.22M | 15.292M | -0.47% | - |
| Q2 2020 | -0.19 | -0.41 | 53.14% | - | 12.72M | 8.976M | 41.71% | - |
| Q1 2020 | 0.03 | -0.15 | 119.94% | - | 17.42M | 14.061M | 23.89% | - |
Notes
CASTLE BIOSCIENCES INC (CSTL) last reported earnings on 2/26/2026.
CASTLE BIOSCIENCES INC (CSTL) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, CASTLE BIOSCIENCES INC (CSTL) has beaten EPS estimates in 3 out of 4 releases.